AAAAAA

   
Results: 1-12 |
Results: 12
Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: A 3.5-year study
Authors: Mahajan, AP Tashima, KT Bausserman, LL Flynn, MM Carpenter, CCJ
Citation: Ap. Mahajan et al., Plateau in body habitus changes and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy: A 3.5-year study, J ACQ IMM D, 28(4), 2001, pp. 332-335
A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use
Authors: Tashima, KT Hogan, JW Gardner, LI Korkontzelou, C Schoenbaum, EE Schuman, P Rompalo, A Carpenter, CCJ
Citation: Kt. Tashima et al., A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use, CLIN INF D, 33(12), 2001, pp. 2055-2060
Photo quiz - Disseminated Rhodococcus equi infection.
Authors: Alonso, P Tashima, KT Goldstein, IJ
Citation: P. Alonso et al., Photo quiz - Disseminated Rhodococcus equi infection., CLIN INF D, 32(6), 2001, pp. 929
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women
Authors: Cohen, RA Boland, R Paul, R Tashima, KT Schoenbaum, EE Celentano, DD Schuman, P Smith, DK Carpenter, CCJ
Citation: Ra. Cohen et al., Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women, AIDS, 15(3), 2001, pp. 341-345
Diagnosis of acute HIV infection: It's time to get moving!
Authors: Flanigan, T Tashima, KT
Citation: T. Flanigan et Kt. Tashima, Diagnosis of acute HIV infection: It's time to get moving!, ANN INT MED, 134(1), 2001, pp. 75-77
Sustained responses to dual nucleoside therapy in women
Authors: Tashima, KT Fiore, TC
Citation: Kt. Tashima et Tc. Fiore, Sustained responses to dual nucleoside therapy in women, J ACQ IMM D, 25(4), 2000, pp. 371-372
Antiretroviral therapy in the year 2000
Authors: Tashima, KT Flanigan, TP
Citation: Kt. Tashima et Tp. Flanigan, Antiretroviral therapy in the year 2000, INF DIS CL, 14(4), 2000, pp. 827
Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
Authors: Dong, KL Bausserman, LL Flynn, MM Dickinson, BP Flanigan, TP Mileno, MD Tashima, KT Carpenter, CCJ
Citation: Kl. Dong et al., Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART), J ACQ IMM D, 21(2), 1999, pp. 107-113
Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis
Authors: Mylonakis, E Merriman, NA Rich, JD Flanigan, TP Walters, BC Tashima, KT Mileno, MD van der Horst, CM
Citation: E. Mylonakis et al., Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis, DIAG MICR I, 34(2), 1999, pp. 111-114
Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C
Authors: Ahmad, M Tashima, KT Caliendo, AM Flanigan, TP
Citation: M. Ahmad et al., Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C, AIDS, 13(10), 1999, pp. 1281-1282
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults
Authors: Staszewski, S Morales-Ramirez, J Tashima, KT Rachlis, A Skiest, D Stanford, J Stryker, R Johnson, P Labriola, DF Farina, D Manion, DJ Ruiz, NM
Citation: S. Staszewski et al., Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults, N ENG J MED, 341(25), 1999, pp. 1865-1873
Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy
Authors: Tashima, KT Caliendo, AM Ahmad, M Gormley, JM Fiske, WD Brennan, JM Flanigan, TP
Citation: Kt. Tashima et al., Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy, J INFEC DIS, 180(3), 1999, pp. 862-864
Risultati: 1-12 |